User profiles for "author:JF Simard"

Julia F Simard

Associate Professor of Epidemiology & Population Health, and Immunology & …
Verified email at stanford.edu
Cited by 8344

Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis

…, A Boutin, F Lauzier, DA Fergusson, JF Simard… - Bmj, 2013 - bmj.com
Objectives To determine the ability and accuracy of the S-100β protein in predicting
prognosis after a moderate or severe traumatic brain injury. Design Systematic review and …

Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies

M Holmqvist, JF Simard, K Asplund, EV Arkema - RMD open, 2015 - rmdopen.bmj.com
Previous studies of stroke in systemic lupus erythematosus (SLE) have had limited statistical
power, combined stroke subtypes into composite outcomes, and lacked a reference …

[HTML][HTML] The representation of gender and race/ethnic groups in randomized clinical trials of individuals with systemic lupus erythematosus

…, Y Chaichian, MB Bass, JF Simard - Current rheumatology …, 2018 - Springer
Abstract Purpose of Review This review evaluated gender and race/ethnic representation in
randomized controlled trials (RCTs) of patients with systemic lupus erythematosus (SLE) …

Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study

AF Turgeon, F Lauzier, JF Simard, DC Scales… - Cmaj, 2011 - Can Med Assoc
Background: Severe traumatic brain injury often leads to death from withdrawal of life-
sustaining therapy, although prognosis is difficult to determine. Methods: To evaluate …

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

…, L Thabane, LG Rider, JS Hausmann, JF Simard… - RMD open, 2021 - rmdopen.bmj.com
Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …

Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden

M Neovius, JF Simard, J Askling… - Annals of the …, 2011 - ard.bmj.com
Objective To provide Swedish nationwide data on the prevalence of rheumatoid arthritis
(RA), including variations by age, sex, geography, demography and education level, and …

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden

P Raaschou, JF Simard, M Holmqvist, J Askling - Bmj, 2013 - bmj.com
Objectives To investigate the potential association between tumour necrosis factor (TNF)
inhibitor treatment and malignant melanomas in rheumatoid arthritis, melanoma risks in …

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab

…, JK Eriksson, LE Kristensen, JF Simard… - Annals of the …, 2015 - ard.bmj.com
Objective To compare drug survival on adalimumab, etanercept and infliximab in patients
with rheumatoid arthritis (RA). Methods Patients with RA (n= 9139; 76% women; mean age …

Incidence of rheumatoid arthritis in Sweden: a nationwide population‐based assessment of incidence, its determinants, and treatment penetration

…, S Ernestam, S Lindblad, JF Simard… - Arthritis care & …, 2013 - Wiley Online Library
Objective To estimate the nationwide incidence of rheumatoid arthritis (RA) in Sweden,
including its variation across age, sex, geography, and demography, and to describe the …

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis

A Finckh, JF Simard, C Gabay, PA Guerne - Annals of the rheumatic …, 2006 - ard.bmj.com
Background: Acquired drug resistance or gradual drug failure has been described with most
disease modifying antirheumatic drugs (DMARDs) and is also starting to be recognised with …